IPO - Asia Tech Wire

IPO

20:17

                            Eli Lilly's new Alzheimer's drug is on the market: the annual drug cost exceeds $30,000, and Pfizer and Roche are planning
                        
                            Following Eisai/Biogen's Lecanemab (Lecanemab), the second new Alzheimer's disease drug approved in China by Eli Lilly has been launched. On December 18, Eli Lilly announced that the world's second new Alzheimer's disease (AD) drug Donanemab injection (trade name: Ji Neng Da) was approved for marketing by the China National Medical Products Administration for the treatment of mild cognitive impairment and mild dementia caused by Alzheimer's disease in adults. Regarding the question of whether the price of the world's second new Alzheimer's disease drug will drop, a medical expert told reporters that this usually depends on a variety of factors, including market demand, drug efficacy, production costs, and market competition. With the development and marketing of more similar drugs, market competition may intensify, prompting prices to fall. However, this also needs to take into account the high cost of drug research and development and the company's profit needs.
                        
16:45

                            CATL has not responded to rumors of listing in Hong Kong
                        
                            Chinese battery giant CATL is considering a secondary listing in Hong Kong, which is scheduled to be completed as early as the first half of 2025, and is expected to raise at least $5 billion, according to Bloomberg.
                        
16:26

                            Regulatory requirements to regulate the public statements of chief economists, securities analysts, fund managers, etc.
                        
                            The reporter has recently learned that the securities regulatory bureaus in many places have recently put forward regulatory requirements for securities companies, etc., aiming to strengthen the management of public speech, especially the management of the external voices of practitioners such as chief economists, securities analysts, and fund managers. According to multiple sources, some securities research institutes have issued internal documents to strengthen the management of analysts, requiring analysts to fully regulate their own words and deeds, strictly abide by the professional standards, and emphasize that research reports are the only standard for opinions. Don't say something out of the ordinary for the sake of eyeballs, don't relax the standards in order to attract customers and echo hot spots, and don't take the chance to test the regulatory red line. A research institute compliance said that many third-party institutions currently accept buyers' commissions and directly access various meetings in the name of buyers, maintain and analyze them through AI, and then disseminate them to the outside world. Compliance clearly requires that practitioners are prohibited from providing listed company research minutes to customers in any way. The relevant minutes can only be archived internally or used as materials for writing research reports.
                        
10:06

                            CATL is reportedly considering listing in Hong Kong to raise at least $5 billion
                        
                            CATL, China's largest battery maker for electric vehicles, may seek a second listing in Hong Kong as soon as 2025 and consider raising at least $5 billion, according to Bloomberg, citing people familiar with the matter.
                        
05:02

                            The three major U.S. stock indexes all closed down more than 2%, and the Dow Jones Industrial Average recorded its longest losing streak in more than half a century.
                        
                            The Federal Reserve announced a 25 basis point rate cut, and Powell said the Fed is at or close to slowing down its rate cuts. The three major U.S. stock indexes all closed sharply lower, with the Nasdaq down 3.56%, the S&P 500 down 2.95%, and the Dow down 2.59%. Among them, the Dow fell for the 10th consecutive day, the longest losing streak since October 1974. Quantum computing hot stocks rose more than 53% against the trend; most of the popular Chinese stocks closed lower, with the Nasdaq China Golden Dragon Index down more than 2%.
                        
20:51

                            Intensifying efforts to give back to investors, the number of companies disclosing interim dividends on the Shanghai Stock Exchange increased by 354% year-on-year
                        
                            The latest data disclosed by the Shanghai Stock Exchange shows that the enthusiasm of Shanghai-listed companies for mid-year and quarterly dividends has increased significantly this year. According to statistics, as of now, there are 481 companies in the Shanghai Stock Exchange that have disclosed mid-term dividends in 2024, an increase of 354% year-on-year, and the amount of dividends reached 574.9 billion yuan, an increase of 184% year-on-year. Some companies have paid dividends twice or even three times this year. Among them, Linglong Tire disclosed dividend plans in the first quarter, mid-term, and third quarter reports this year, with cash dividends per share of 0.091 yuan, 0.1 yuan, and 0.162 yuan, respectively. In addition, Shanghai-listed companies such as Kweichow Moutai, China Nuclear Power, Will Group, China Power, and Anjing Foods have all launched dividends twice this year.
                        
22:31

                            At the opening of the US stock market, the Dow Jones Industrial Average rose 56 points, the S&P 500 rose 0.23%, and the Nasdaq rose 0.47%. Micron Technology (MU.O) rose 2.4%, and Wall Street expects the company's Q1 revenue in fiscal year 25 to increase significantly year-on-year; MicroStrategy (MSTR.O) rose 3.8%, and the company entered the Nasdaq 100 Index. The Nasdaq China Golden Dragon Index fell 1.7%.
                        
15:43

                            Huawei's EV partner Seres could make secondary listing in Hong Kong
                        
                            Huawei's electric vehicle partner Seres is considering a secondary listing in Hong Kong in order to raise further capital, according to multiple media reports.
                        
15:18

                            LG said to raise IPO valuation of India business to $15 billion
                        
                            South Korea's LG Electronics has raised the IPO valuation of its Indian business to $15 billion, according to Bloomberg.
                        
09:10

                            Eli Lilly and Innovent Biologics reach commercialization agreement for Jepali (pitubutinib tablets) in mainland China
                        
                            On December 16, Eli Lilly and Company and Innovent Biologics Group jointly announced that they had reached the following cooperation agreement on the rights of Eli Lilly's non-covalent (reversible) BTK inhibitor Jepali (pitumbrina 100 mg and 50 mg tablets) in mainland China: Innovent Biologics will be responsible for the import, sales, promotion and distribution of Jepali; Eli Lilly will be responsible for the research and development and post-marketing medical affairs of Jepali.
                        
12:00

                            Nasdaq 100 has been rebalanced with PLTR and MSTR
                        
12:24

                            Jiangshan Holdings' AI company suddenly announced its dissolution: no funds to continue, all employees dismissed
                        
                            Eagle Eye Smart Chinese Medicine, an AI medical company under the listed company Jiangshan Holdings, recently suddenly announced its dissolution and dismissed all employees. Several Eagle Eye Smart Chinese Medicine employees told Sina Technology that at 23:31 on the night of December 9, Lv Jiyou, general manager of the company's strategic management department and director of the president's office, suddenly issued a dissolution notice in the company's WeChat group for all employees. The notice stated that due to huge problems encountered in the company's operations and the lack of funds, the shareholders decided that the company would be dissolved and all employees would be dismissed from December 9, 2024. The salary of all employees will be calculated until December 9, 2024, and social security and provident fund payments will be made until November. The social security, medical insurance, personal income tax and provident fund payments for previous months will be completed later, and the unpaid wages will be paid in batches according to the resignation situation.
                        
09:51

                            Jiangshan Holdings' AI company Eagle Eye Smart Chinese Medicine suddenly disbanded
                        
                            According to Sina Technology, Eagle Eye Smart Chinese Medicine, an AI medical company under Hong Kong-listed company Jiangshan Holdings, suddenly announced its dissolution recently, and all employees were dismissed. Lv Jiyou, general manager of the company's strategic management department and director of the president's office, issued a dissolution notice, saying that the company's operations encountered huge problems and funds were unsustainable. After research and decision by shareholders, the company will be dissolved and all employees will be dismissed from December 9, 2024. Employee salaries will be calculated until December 9, 2024, and social security and provident fund payments will be made until November. The company provided a dissolution plan, but some employees complained that the plan was a tactical delay, and it was not certain whether it would be issued.
                        
03:42

                            The amount of A-share repurchases has exceeded 160 billion yuan this year, and "cancellation" has become the mainstream
                        
                            Data shows that 2,446 repurchase plans have been implemented so far this year, involving an amount of more than 160 billion yuan, far exceeding the level of the whole of last year. What is different from the past is that this round of repurchases is characterized by strong intensity, short term, fast implementation, and a large number of cancellation-style repurchases. At the same time, with the support of special loans for stock purchases, more and more listed companies are joining the repurchase team. In addition to Hikvision, Kweichow Moutai plans to implement a share repurchase plan with 3 billion to 6 billion yuan of its own funds. The repurchased shares will be used to cancel and reduce the company's registered capital. In addition, companies such as WuXi AppTec, Jiuan Medical, and Yili Group have disclosed repurchase plans with a maximum limit of more than 1 billion yuan, and all of them will be used for capital reduction and cancellation.
                        
17:52

                            Huadong Medicine: A wholly-owned subsidiary received the Drug Registration Certificate approved and issued by the National Medical Products Administration (NMPA)
                        
                            Huadong Medicine announced that Hangzhou Sino-US Huadong Pharmaceutical Co., Ltd. (hereinafter referred to as "Sino-US Huadong"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (hereinafter referred to as "the Company"), received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration (NMPA). The marketing authorization application for Rilonacept for Injection (trade name: Yanduo®/ARCALYST®) submitted by Sino-US Huadong for the treatment of recurrent pericarditis (RP) was approved.
                        
1735215450
101911
13

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Trends

electric vehicle China Tesla Chinese Company South Korea AI Apple Samsung India Huawei

Weekly Highlights

                                    Taiwan's weighted index rose 2.6%, with semiconductor stocks leading the gains, and TSMC rising more than 4%
                            2024-12-23

                                    Tuanmaimai, the WeChat community group buying business under Meituan (03690.HK), issued an announcement stating that due to platform business adjustments, Tuanmaimai will cease operations from 24:00 on December 31, 2024.
                            2024-12-23

                                    MediaTek releases AI chip Dimensity 8400, equipped with Dimensity AI intelligent engine
                            2024-12-23

                                    Japanese regulators intend to order Google to rectify its actions for suspected monopoly, the company responded
                            2024-12-23

                                    Xiaomi Motors officially integrates VLM visual language model
                            2024-12-23